Key result
Unsupervised cluster phenotyping identifies three distinct mortality risk profiles in young PCI-treated ACS patients.
Why the study?
Does unsupervised machine learning identify distinct phenotypic clusters with different mortality risks in young patients with ACS undergoing PCI?
Observational (n=452)
Does unsupervised machine learning identify distinct phenotypic clusters with different mortality risks in young patients with ACS undergoing PCI?
Unsupervised machine learning identified three distinct phenotypic clusters among young ACS patients undergoing PCI, with the high-risk cluster exhibiting a fourfold higher risk of all-cause mortality.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for phenotype-guided strategies in young ACS post-PCI; prospective trials required before clinical adoption.
BACKGROUND: Young patients with acute coronary syndrome (ACS) exhibit diverse demographic, clinical and angiographic characteristics. We hypothesized that unsupervised machine learning (ML) can identify phenotypic clusters and predict the prognosis among young patients with ACS who undergo percutaneous coronary intervention (PCI). METHODS: We used the Houston Methodist Young-ACS PCI registry (2010-2022) and performed agglomerative clustering to analyze demographic, clinical, and angiographic variables among young patients (≤ 50 years) treated with PCI for ACS. RESULTS: Among 452 patients, cluster analysis identified three distinct phenotypes. Low risk (n = 273) exhibited the lowest proportions of heart failure (HF: 10.3%) and peripheral arterial disease (PAD): 5.9%), normal left ventricular ejection fraction (LVEF) (median = 0.60) and shorter median culprit vessel stent length (16 mm). Moderate risk (n = 101) was characterized by moderate rates of diabetes (36.6%), hypertension (77.2%), prior myocardial infarction (16.8%), and prior PCI (18.8%). High risk (n = 78) had the highest proportion of diabetes (67.9%), hypertension (93.6%), HF (65.4%), PAD (17.9%), prior MI (41.0%), prior PCI (46.2%), the lowest median LVEF (0.3) and the most frequent use of mechanical circulatory device (5.1%). All-cause mortality differed significantly, with high-risk cluster showing a fourfold increase in all-cause mortality (HR: 4.50 [1.68-12.1]) compared to low-risk cluster; however moderate and low-risk clusters did not differ significantly (HR: 1.52 [0.44-5.19]). Sensitivity analysis based on two-clusters showed similar outcomes, indicating the robustness of the analysis. CONCLUSIONS: Three distinct phenotypic clusters among young patients with ACS treated with PCI exhibited varying degrees of comorbidity burden and mortality risk, underscoring the potential for phenotype-guided therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Maqsood et al. (2026) conducted an observational in Acute Coronary Syndrome (n=452). High-risk phenotypic cluster vs. Low-risk phenotypic cluster was evaluated on All-cause mortality (HR 4.50, 95% CI 1.68-12.1). A high-risk phenotypic cluster of young patients with ACS undergoing PCI showed a fourfold increase in all-cause mortality compared to a low-risk cluster.
Synapse has enriched 10 related papers. Consider them for comparative context: